Angiogenesis Inhibitors: all 4,430 studies that test it
Page 34 of 45. Open to participants first (542), then studies with results posted, then the rest; newest registration first within each.
- Evaluation of Wet Age-Related Macular Degeneration (AMD) Genetic Profile Interactions With Ranibizumab Treatment OutcomesCompletedNCT01363570Not applicable
- Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic TherapyStatus unknownNCT01360151Not applicable
- Anti-CXCR4 (BMS-936564) Alone and in Combination With Lenalidomide/Dexamethasone or Bortezomib/Dexamethasone in Relapsed/Refractory Multiple MyelomaCompletedNCT01359657Phase 1
- Docetaxel, Oxaliplatin, Capecitabine, Bevacizumab and Trastuzumab in Patients With Locally Advanced or Metastatic Gastric CancerStatus unknownNCT01359397Phase 2
- Gemcitabine, Carboplatin, and Lenalidomide for Treatment of Advanced/Metastatic Urothelial Cancer and Other Solid TumorsCompletedNCT01352962Phase 1
- Revlimid, Endoxan, Prednison Evaluation After Prior Revlimid Treatment (REPEAT)CompletedNCT01352338Phase 1/2
- Lenalidomide in Combination With a Fixed Dose of Sorafenib for the Treatment of Hepatocellular CarcinomaTerminatedNCT01348503Phase 1
- Evaluating Endostatin Plus TC Regimen in Secondary Malignant Neoplasm of Liver Using Contrast Enhancement UltrasonographyStatus unknownNCT01347424Phase 2
- THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)CompletedNCT01341262Phase 2
- High Dose Intravitreal Ranibizumab for Recalcitrant Radiation RetinopathyCompletedNCT01334879Phase 1
- Safety Evaluation of a Combination of Brain Radiation Therapy and Bevacizumab (Avastin®) for Treatment of Brain MetastasisCompletedNCT01332929Phase 1
- GDC-0980 in Combination With a Fluoropyrimidine, Oxaliplatin, and Bevacizumab in Patients With Advanced Solid TumorsCompletedNCT01332604Phase 1
- A Pharmacokinetic Study of AMG 386 in Cancer Subjects With Normal and Impaired Renal FunctionCompletedNCT01331941Phase 1
- Optic Neuropathy in 10 Patients With Glioblastoma Receiving BevacizumabWithdrawnNCT01331616Early Phase 1
- Comparison of Intravitreal Bevacizumab and Triamcinolone With PlaceboStatus unknownNCT01330524Phase 1/2
- Endostar and/or Cisplatin for Treatment of Malignant Pleural Effusion or AscitesCompletedNCT01327235Phase 2
- Intravitreal Bevacizumab for Low Vision in Neovascular Age-related Macular Degeneration (AMD)CompletedNCT01327222Phase 3
- Efficacy of FOLFOX+Bevacizumab in Combination With Irinotecan in the Treatment of Metastatic Colorectal CancerCompletedNCT01321957Phase 2
- Bevacizumab and Trastuzumab With Weekly Paclitaxel Followed, After Surgery, by Encapsuled Liposomal Doxorubicin, Cyclophosphamide and Trastuzumab as Adjuvant Treatment After Surgery on Women With Her2+ Breast CancerStatus unknownNCT01321775Phase 2
- Ranibizumab and the Risk of Arterial Thromboembolic EventsTerminatedNCT01319188Phase 4
- A Clinical Study in Current Medical Practice of the Efficacy and Safety of Ranibizumab 0.5mg in Diabetic Patients Presenting a Visual Impairment Due to Macular EdemaCompletedNCT01315275Phase 4
- Intranasal Submucosal Bevacizumab for Epistaxis in Hereditary Hemorrhagic Telangiectasia (HHT)CompletedNCT01314274Phase 2
- Efficacy of Bevacizumab in Preventing Acute Respiratory Distress Syndrome (ARDS)WithdrawnNCT01314066Phase 2
- Autologous T-Cells Combined With Autologous OC-DC Vaccine in Ovarian CancerTerminatedNCT01312376Phase 1
- Recombinant Human Endostatin in Combination With mFOLFOX6 in Patients With Metastatic Colorectal CancerStatus unknownNCT01310478Phase 1
- Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Induction Therapy for Locally Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT01309633Phase 2
- A Dose- and Efficacy-Finding Study of RO5323441 in Combination With Avastin (Bevacizumab) in Patients With Recurrent GlioblastomaCompletedNCT01308684Phase 1
- Study of Continuous Dosing of Sunitinib in Non GIST Sarcomas With Concomitant RadiotherapyCompletedNCT01308034Phase 1
- Rituximab With or Without Lenalidomide in Treating Patients With Previously Untreated Follicular LymphomaTerminatedNCT01307605Phase 2
- Gemcitabine Hydrochloride, Rituximab, Oxaliplatin, and Lenalidomide in Treating Patients With Relapsed or Refractory, Aggressive Non-Hodgkin LymphomaStatus unknownNCT01307592Phase 2
- Ranibizumab in Diabetic Vitrectomy. A Prospective, Randomised Controlled Trial of Ranibizumab Pre-treatment in Diabetic Vitrectomy - a Pilot StudyCompletedNCT01306981Phase 4
- Bevacizumab for Neovascular Age-related Macular DegenerationCompletedNCT01306591Not applicable
- Efficacity of Weekly Paclitaxel in Association or Not With Bevacizumab in Metastatic or Locally Advanced AngiosarcomasCompletedNCT01303497Phase 2
- Elderly Patients With Acute Myeloid Leukemia (AML), Maintenance Phase After Complete Remission (CR)CompletedNCT01301820Phase 2
- A Study of the Safety and Pharmacology of GDC-0980 in Combination With Either Paclitaxel and Carboplatin (With or Without Bevacizumab) or Pemetrexed and Cisplatin in Patients With Solid TumorsCompletedNCT01301716Phase 1
- Intravitreal Bevacizumab (Avastin®) Versus Intravitreal Dexamethasone (Ozurdex™) for Persistent Diabetic Macular OedemaCompletedNCT01298076Phase 2
- A Study of Carfilzomib, Lenalidomide, Vorinostat, and Dexamethasone in Relapsed and/or Refractory Multiple MyelomaActive, not recruitingNCT01297764Phase 1/2
- Ranibizumab "Treat and Extend" in Diabetic Macular EdmaCompletedNCT01297569Phase 4
- Thalidomide Plus Dexamethasone as Maintenance Therapy for Multiple MyelomaCompletedNCT01296503Phase 3
- IXO+A in mCRC With Liver-only MetastasesWithdrawnNCT01293942Phase 2
- Bevacizumab and Lomustine for Recurrent GBMCompletedNCT01290939Phase 3
- Randomized Controlled Trial of Subconjunctival Bevacizumab Injection in Impending Recurrent PterygiumCompletedNCT01288404Not applicable
- Use of Individual Pharmacokinetically (PK)-Guided Sunitinib Dosing: A Feasibility Study in Patients With Advanced Solid TumorsCompletedNCT01286896Phase 1
- Bevacizumab and BKM-120 in Patients With Metastatic Renal Cell CarcinomaCompletedNCT01283048Phase 1
- Lenalidomide in Kaposi Disease Associated With HIV InfectionTerminatedNCT01282047Phase 2
- Bevacizumab With Etoposide and Cisplatin in Breast Cancer Patients With Brain and/or Leptomeningeal MetastasisCompletedNCT01281696Phase 2
- Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal CancerCompletedNCT01274624Phase 1
- A Randomized Study With Oral Melphalan + Prednisone (MP) Versus Melphalan, + Prednisone + Thalidomide (MPT) for Newly Diagnosesd Elderly Patients With Multiple MyelomaCompletedNCT01274403Phase 2
- Study of Interleukin-2, Interferon-alpha and Bevacizumab in Metastatic Kidney CancerStatus unknownNCT01274273Phase 2
- Lenalidomide in Treating Patients With High-Risk Chronic Lymphocytic LeukemiaWithdrawnNCT01271283Phase 2
- Glivec® Plus m-FOLFOX Avastin® in Advanced Colorectal CancerTerminatedNCT01271166Phase 1
- Lenalidomide & High Dose Dexamethasone for Untreated Multiple Myeloma Renal Failure PatientsCompletedNCT01270932Phase 2
- Ranibizumab Short- and Log-term Effects on Retinal Function in wAMDCompletedNCT01269151Not applicable
- Safety of and Immune Response to an Investigational HIV-1 Vaccine With or Without Interleukin-12 (IL-12) in HIV-1 Infected AdultsCompletedNCT01266616Phase 1
- Efficacy and Safety of Bevacizumab/Temsirolimus Combination to Treat Advanced Renal Cell CarcinomaTerminatedNCT01264341Phase 2
- Safety And Efficacy Of Lenalidomide As Maintenance Therapy In Patients With Newly Diagnosed Multiple Myeloma Following A Tandem Autologous-Allogeneic TransplantCompletedNCT01264315Phase 2
- Results of Adjunctive Intraoperative Bevacizumab Injection on Trabeculectomy OutcomeCompletedNCT01263834Phase 2/3
- Pilot Study for Locally Advanced Head and Neck CancerWithdrawnNCT01262859Phase 2
- Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial TreatmentCompletedNCT01257815Phase 4
- Evaluation of the Effect of Vitreous Composition Determined by Ultrasound and Optical Coherence Tomography (OCT) on Ranibizumab TherapyCompletedNCT01256632Not applicable
- Intravitreal Bevacizumab vs.Combination Therapy for CNV Due to Other Than AMDWithdrawnNCT01256580Not applicable
- Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis TherapyStatus unknownNCT01255774Phase 3
- Lenalidomide and Cetuximab in Treating Patients With Advanced Colorectal Cancer or Head and Neck CancerCompletedNCT01254617Phase 1
- Lenalidomide After Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic CancersCompletedNCT01254578Phase 1
- Study of the Safety and Pharmacology of GDC-0980 in Combination With Paclitaxel With or Without Bevacizumab in Patients With Locally Recurrent or Metastatic Breast CancerCompletedNCT01254526Phase 1
- Ranibizumab as a Rescue Therapy for Diabetic Macular EdemaWithdrawnNCT01253694Phase 2
- Study of AMG 386 in Combination With Paclitaxel and Carboplatin in Subjects With Ovarian CancerCompletedNCT01253681Phase 1
- EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid TumorsCompletedNCT01251926Phase 1
- Efficacy Study of PAD and TAD in Newly Diagnosed Multiple MyelomaStatus unknownNCT01249690Phase 4
- Dual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal CancerStatus unknownNCT01249521Phase 2
- Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal VasculopathyStatus unknownNCT01248117Phase 1/2
- Lenalidomide and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT01246622Phase 1
- Study Assessing Safety and Efficiency of the Lenalidomide and Dexamethasone Combination in Patients With Chronic Lymphatic Leukemia (CLL) Relapsing or Resistant to TreatmentCompletedNCT01246557Phase 1/2
- Ranibizumab for Myopic NeovascularizationStatus unknownNCT01246089Phase 4
- Study of REVLIMID (Lenalidomide) Versus Placebo in Patients With Low Risk Myelodysplastic SyndromeCompletedNCT01243476Phase 3
- Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid MalignanciesCompletedNCT01243359Phase 1
- Treatment of Epiretinal Membranes With RanibizumabCompletedNCT01238393Not applicable
- Sunitinib + Docetaxel as Second-line Treatment in Gastric CancerCompletedNCT01238055Phase 2
- Study of Treatment for Newly Diagnosed Multiple Myeloma Patients Older Than 65 Years With Sequential Melphalan/Prednisone/Velcade (MPV) Followed by Revlimid/Low Dose Dexamethasone (Rd) Versus Alternating Velcade/Melphalan/Prednisone (MPV) With Revlimid/Low Dose DexamethasoneCompletedNCT01237249Phase 2
- Pan-VEGF Blockade for the Treatment of Retinopathy of Prematurity (BLOCK-ROP)WithdrawnNCT01232777Phase 2
- Avastin and Chemotherapy Followed by a KRAS Stratified Randomization to Maintenance Treatment for First Line Treatment of Metastatic Colorectal Cancer.CompletedNCT01229813Phase 3
- Use of Bevacizumab to Modulate the Outcomes of Trabeculectomy SurgeryWithdrawnNCT01229202Phase 4
- Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment EvaluationCompletedNCT01223612Phase 4
- Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine GliomasCompletedNCT01222754Phase 1
- Study of Intraperitoneal Carboplatin with IV Paclitaxel and Bevacizumab in Untreated Ovarian CancerCompletedNCT01220154Phase 1
- Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell CarcinomaStatus unknownNCT01219751Phase 2
- Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START TrialActive, not recruitingNCT01217931Phase 2
- Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the EyeStatus unknownNCT01217398Phase 2
- Trial of Single Agent Sunitinib for Patients With Chemo-refractory Metastatic MelanomaTerminatedNCT01216657Phase 2
- Resection of Pulmonary Metastasis in Clear Cell Renal Cell Carcinoma +/-Adjuvant Sunitinib Therapy (SMAT)TerminatedNCT01216371Phase 2
- Predictive Biomarkers of Response to Sunitinib in the Treatment of Poorly-differentiated NEURO-Endocrine TumorsTerminatedNCT01215578Phase 2
- Study of Sunitinib in Patients With Advanced/Inoperable Fibrolamellar CarcinomaTerminatedNCT01215565Phase 2
- Genetics in Non-response to Anti-VEGF Treatment in Exudative AMDStatus unknownNCT01213667Phase 4
- Hepatic Arterial Infusion Oxaliplatin, Capecitabine With or Without BevacizumabCompletedNCT01213238Phase 1
- Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerStatus unknownNCT01210053Phase 2
- Bevacizumab, Docetaxel, and Carboplatin in Treating Women With Stage II or Stage III Breast CancerCompletedNCT01208480Phase 2
- Lenalidomide Maintenance Therapy Post Autologous Transplant for Hodgkins LymphomaCompletedNCT01207921Phase 1
- FOLFOX/Bevacizumab/Hydroxychloroquine (HCQ) in Colorectal CancerCompletedNCT01206530Phase 1/2
- Frontline Therapy in de Novo Multiple Myeloma Patients Under 65CompletedNCT01206205Phase 2
- Combination Chemotherapy Plus Panitumumab or Bevacizumab for Inoperable Cholangiocarcinoma Without KRAS MutationsCompletedNCT01206049Phase 2